VKTX
Viking Therapeutics Inc
28.50$
+0.6%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -3.7% | +162.6% | -2.1% | -0.9% | -3.2% | -4.5% | -4.5% | -10.7% | -3.2% | -15.0% | -14.2% | |
| – | -3.7% | +163.1% | -2.1% | -1.0% | -3.1% | -4.5% | -4.5% | -10.7% | -3.1% | -15.0% | -14.9% | |
| – | +49.3% | +252.3% | -77.5% | +14.6% | -47.0% | +42.2% | -10.7% | +196.3% | +65.2% | -28.8% | +6.5% | |
| – | -3.8% | +166.0% | -2.2% | -1.3% | -3.0% | -5.6% | -5.2% | -11.5% | -1.2% | -14.6% | -16.8% | |
| – | +39.2% | +67.5% | -23.1% | +2.2% | +6.1% | -28.4% | +61.3% | -18.5% | +190.6% | +38.7% | +6.8% | |
| – | +42.7% | +71.3% | -23.4% | +2.4% | +6.7% | -28.6% | +63.4% | -18.5% | +194.1% | +38.7% | +3.1% | |
| – | +1.6% | +1.5% | +1.5% | +43.7% | +1.9% | +1.8% | -6.0% | -6.6% | -68.6% | – | – | |
| – | +31.5% | -30.4% | +112.2% | -97.7% | +3,763.4% | -21.5% | -28.7% | -19.7% | +1,106.7% | +26.2% | +2.7% | |
| – | -5.4% | +168.0% | -1.4% | -1.0% | -3.4% | -3.8% | -6.1% | -10.4% | -10.4% | -21.5% | -18.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.3% | +3.3% | +6.7% | +0.5% | +0.4% | +0.7% | +0.1% | +0.2% | +1.5% | +1.4% | +0.3% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.